Are nodal metastases in ovarian cancer chemoresistant lesions? Analysis of nodal involvement in 105 patients treated with preoperative chemotherapy.
Explore this paper's citation graph
Summary
The rates of nodal involvement seem to be similar in patients treated before or after chemotherapy, and results suggest that nodal metastases are not as chemosensitive as peritoneal lesions.
- Type
- article
- Published
- 2004-01-01
- Cited by
- 53
- References
- 0
- OpenAlex
- https://openalex.org/W50025648
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:38150471
Keywords
Medicine, Debulking, Regimen, Lymphadenectomy, Chemotherapy
References
No references recorded for this paper.
Cited by
- Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma.
- Ovarian clear cell adenocarcinoma: a continuing enigma
- Ovarian cancer: pathology, biology, and disease models.
- Estudio comparativo entre cirugía primaria y cirugía de intervalo en el estadio iiic del cáncer de ovario
- Establishment of Fischer 344 rat model of ovarian cancer with lymphatic metastasis
- Outcomes After Combined Therapy Including Surgical Resection in Patients with Epithelial Ovarian Cancer Recurrence(s) Exclusively in Lymph Nodes
- Location of aortic node metastases in locally advanced cervical cancer.
- Anatomy of pelvic and para-aortic nodal spread in patients with primary fallopian tube carcinoma.
- Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer.
- Percutaneous ablation of lymph node metastases using CT-guided high-dose-rate brachytherapy.
- Differential routes of carboplatin administration influence lymphocyte apoptosis in retroperitoneal lymph nodes
- Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors.
- Large animal model for retroperitoneal lymphatic and lung metastasis
- Chirurgia dei tumori epiteliali maligni dell’ovaio
- Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery
- The case of robotics and the infrarenal aortic nodes.
- Lymphadenectomy in ovarian cancer: standard of care or unnecessary risk
- Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials.
- Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
- Systematic lymphadenectomy in advanced epithelial ovarian cancer: two decades of uncertainty resolved.
Related papers
- A case of chronic paclitaxel administration in ovarian cancer.
- Combination Intraperitoneal Carboplatin and Intravenous and Intraperitoneal Paclitaxel in the Management of Advanced-Stage Ovarian Cancer
- Neoadjuvant chemotherapy prior to intraperitoneal chemotherapy in women with advanced ovarian cancer
- Therapeutic strategy in the management of stage II-IV epithelial ovarian carcinoma.
- Intraperitoneal Chemotherapy for Ovarian Cancer Prolongs Survival
- Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study
- Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer.
- Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.